Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Maze Therapeutics, Inc. (MAZE) vs. Competitors

128 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
MAZEMaze Therapeutics, Inc.$34.33$1.88B-11.967.82%Strong BuyUnlock the MAZE analyst price target with TipRanks PremiumMAZEUnlock the MAZE top-analyst price target with TipRanks Premium
NTLAIntellia Therapeutics$9.70$1.36B-2.9011.88%HoldUnlock the NTLA analyst price target with TipRanks PremiumMAZE vs NTLAUnlock the NTLA top-analyst price target with TipRanks Premium
DMRADamora Therapeutics$21.60$1.34B-0.17-22.41%Strong BuyUnlock the DMRA analyst price target with TipRanks PremiumMAZE vs DMRAUnlock the DMRA top-analyst price target with TipRanks Premium
RXRXRecursion Pharmaceuticals$3.19$1.99B-3.54-26.44%Moderate BuyUnlock the RXRX analyst price target with TipRanks PremiumMAZE vs RXRXUnlock the RXRX top-analyst price target with TipRanks Premium
DNAGinkgo Bioworks Holdings$9.61$622.89M-2.2820.12%Moderate SellUnlock the DNA analyst price target with TipRanks PremiumMAZE vs DNAUnlock the DNA top-analyst price target with TipRanks Premium
GENBGenerate Biomedicines, Inc.$12.07$1.56B-5.09-4.58%Strong BuyUnlock the GENB analyst price target with TipRanks PremiumMAZE vs GENBUnlock the GENB top-analyst price target with TipRanks Premium

Performance Comparison

-50%-25%0%25%50%75%100%125%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
MAZEMaze Therapeutics, Inc.34.330.802.39%
NTLAIntellia Therapeutics9.701.2214.39%
DMRADamora Therapeutics21.60-1.25-5.47%
RXRXRecursion Pharmaceuticals3.19-0.94-22.69%
DNAGinkgo Bioworks Holdings9.611.8323.52%
GENBGenerate Biomedicines, Inc.12.07-0.58-4.58%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts